Has Jared Ament received payments from drug or device companies?

Yes. Drug and device makers reported $1,103,102 in general payments to Jared Ament across 263 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jared Ament did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jared Ament come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jared Ament

Neurological Surgery · West Hills, CANPI 1356653927

Payments from drug & device makers

$1,103,102in general payments, 2019–2025

Across 263 payments — averaging $4194.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Spineart SA$427K
Spineart USA Inc$278K
Orthofix Medical, Inc.$203K
Premia Spine, Ltd.$102K
Paradigm Spine, LLC$45K
7d Surgical Inc.$16K
plus $32K from 36 others

What the payments were for

Consulting fees$80,89175%
Speaking & faculty fees$7,6697%
Travel & lodging$12,71412%
Food & beverage$7,0647%
Education$1970%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Spineart SA	38	$427,231
Spineart USA Inc	16	$277,522
Orthofix Medical, Inc.	42	$203,381
Premia Spine, Ltd.	16	$101,924
Paradigm Spine, LLC	1	$45,000
7d Surgical Inc.	7	$15,688
Cerapedics Inc.	10	$13,280
Globus Medical(2 entities)	32	$10,481
Stryker	10	$1,811
Aesculap Implant Systems, LLC	1	$1,650
CTL Medical Corporation	2	$1,368
Surgalign Spine Technologies, Inc.	6	$847
Medtronic(3 entities)	11	$537
Abbott	12	$458
Zimmer Biomet	4	$322
Integrity Implants Inc.	2	$220
AbbVie(2 entities)	7	$167
Centinel Spine, LLC	2	$165
UCB, Inc.	5	$125
Medacta USA, Inc.	1	$123
Novartis	6	$113
Portola Pharmaceuticals, LLC	4	$80
AstraZeneca(2 entities)	3	$80
Acorda Therapeutics, Inc	3	$69
Alphatec Spine, Inc	3	$65
Baxter Healthcare	2	$57
Avanir Pharmaceuticals, Inc.	2	$50
Biogennix, LLC	1	$32
Arteriocyte Medical Systems, Inc.	1	$30
Adamas Pharmaceuticals, Inc.	1	$25
Sanofi	1	$24
Neurocrine Biosciences, Inc.	1	$23
Ceribell, Inc.	1	$23
Argenx US, Inc.	1	$20
Integra Lifesciences Corporation	1	$16
GT Medical Technologies, Inc	1	$16
Spineology Inc.	1	$15
Biogen	1	$15
Lilly USA, LLC	1	$13
Kyowa Kirin, Inc.	1	$13
Augmedics Inc.	1	$12
Boston Scientific	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

coflex$45,480
I-FACTOR PEPTIDE ENHANCED BONE GRAFT$14,964
TOPS$8,375
ELSA$6,736
Perla TL$3,917
i-FACTOR Putty$2,110
ACTIVL ARTIFICIAL DISC$1,650
M6-C$1,457
ELSA ATP$1,440
AVAFLEX$1,343
Excelsius - GPS$1,187
N/A$792
SPINEJACK$792
Scarlet AL-T$250
ALIF$224
CORBEL$219
AIRO$216
Mobi-C$197
ALLOGRAFT$171
Prodigy Family of SCS IPGs$167

How this compares

$1,103,102 in reported general payments places this provider in the 95th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024

$207,956

Medicare patients

225

Services billed

579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	13	$125
Pregabalin	15	$81

Paid to pharmacies, not to this prescriber.

Other neurological surgery in West Hills

Geoffrey ManleySan Francisco$24.9M
Christopher AmesSan Francisco$7.1M
Jamshid SalehRedding$4.1M
Bruce McCormackSan Francisco$3.9M
Andrew SchreiberSanta Ana$3.9M
Larry KhooLos Angeles$3M
Jennie TaylorSan Francisco$2.7M
Joseph CiacciSan Diego$2.6M
Nicholas ButowskiSan Francisco$2.4M
Samy AbdouSan Diego$2.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →